Developer docs
API playgroundTry for free, no card

Search company profiles

Akido Labs

Full company profile

uuid0000a53

Namestring
Akido Labs
Legal namestring
Akido Labs, Inc.
Websiteurl
akidolabs.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Akido Labs is a Los Angeles-based, AI-native care delivery company founded in 2015 that operates an integrated medical network (the Akido Care network) spanning 96+ locations across California, Rhode Island, and New York, with 245 providers across 26 specialties serving more than 500,000 patients and 620,000 patient visits per year. Its foundational technology is ScopeAI, a proprietary clinical AI platform the company describes as 'the first AI operating system designed specifically for healthcare,' trained on what it calls the world's most powerful health data corpus and refined via reinforcement learning with human feedback (RLHF) from its in-network clinicians. ScopeAI is delivered to physicians through Akido Chart EMR, an in-house electronic medical record system that blends AI-generated diagnoses, treatment plans, and risk forecasts with clinician review, and is also deployed in field settings via tablets that enable community health workers to conduct AI-guided intakes for hard-to-reach populations.

Akido generates revenue primarily through fee-for-service and risk-bearing care contracts across commercial payers and government programs, including 100% Medi-Cal (California Medicaid) reimbursement for its street medicine and Enhanced Care Management (ECM) safety-net programs under CalAIM. The company's go-to-market combines direct care delivery (Akido Care clinics, mobile street-medicine units, Akido Medical in Brooklyn), channel partnerships (a JV with Rhode Island Primary Care Physicians Corporation, affiliation with Chaparral Medical Group), and targeted community programs (NYC ride-share driver mobile clinics, unhoused and substance-use-disorder populations in LA, Kern County, and the Bay Area). It has raised over $100M in cumulative venture funding, most recently a $60M Series B led by Oak HC/FT in May 2025, and reports 300% year-over-year run-rate growth into mid-nine figures as of January 2026. Strategic leadership additions in early 2026 (Matt Siegler as Chief Network Officer, Jack Greco on the board) and academic partnerships with Caltech's Merkin Institute and USC's Keck School of Medicine support a stated goal of national expansion in 2026.

Short descriptiontext

Akido Labs is an AI-native care delivery company operating the Akido Care medical network across 96+ locations in California, Rhode Island, and New York, using its proprietary ScopeAI platform to deliver primary, specialty, and safety-net care to over 500,000 patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI healthcare platform, clinical intelligence software, medical network services, safety net healthcare, street medicine programs
Industry2 codes
PRIMARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHLAFAFAN
Post-Acute Care Networks & Care Management Organizations
Healthcare & Life Sciences/Healthcare Providers & Systems/Post-Acute Care & Rehabilitation Facilities
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
AI-Enabled Healthcare Delivery
Social media profiles1 record
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Patient Care Services (Akido Care)
TypeManaged Services
Description

Direct healthcare delivery through the Akido Care medical network of 96+ locations across primary care and 26 specialties; 620,000 patient visits per year generating service revenue across commercial and government payers.

akidolabs.com
2Medi-Cal Reimbursements (Safety Net Programs)
TypeManaged Services
Description

100% of street medicine and Enhanced Care Management program costs are covered by Medi-Cal (California Medicaid) reimbursements, including services under the CalAIM Medicaid program.

akidolabs.com
3Risk-Bearing Care Models
TypeManaged Services
Description

Akido operates risk-bearing care models as an AI-native health system, taking financial accountability for patient outcomes; the company is seeing 300% growth into mid-nine figures run rate.

prnewswire.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1Medi-Cal-covered safety net services (Street Medicine, Enhanced Care Management)
ModelOther
Notes

Not publicly disclosed; services delivered through Akido Care provider network

akidolabs.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Akido Care
Description

Akido's primary care and specialty care medical network offering primary care, specialty care, and safety-net services (including street medicine and enhanced care management) across California, Rhode Island, and New York.

akidolabs.com
+2 more records
Core offering1 text field

Akido Labs operates an AI-native health system that combines its proprietary ScopeAI clinical intelligence platform with a directly operated medical network (Akido Care) of 96+ locations and 245 providers across 26 specialties. ScopeAI delivers streamlined diagnosis, optimized diagnostics, personalized treatment planning, and forecasted health risk predictions, embedded within the Akido Chart EMR and refined via RLHF from Akido's clinicians. Patient-facing services include primary care, specialty care, and safety-net programs such as Street Medicine and Enhanced Care Management, serving 500,000+ patients across California, Rhode Island, and New York.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 13 values shown
  • 53% of patients see a medical provider on their first day of engagement in street medicine programs
+12 more records
Product overview1 text field

Akido Labs operates a single integrated offering composed of a core AI platform delivered through a medical network, rather than a set of standalone products. The centerpiece is Scope AI — Akido's proprietary clinical AI operating system, which is delivered to clinicians through Akido Chart EMR. Scope AI powers all clinical workflows across the Akido Care medical network, which spans 96+ locations, 240+ providers across 26 specialties, and more than 500,000 patients across California, Rhode Island, and New York. Akido Care is organized into three service lines: Primary Care, Specialty Care, and Safety Net Services (which include the Street Medicine program launched in 2023 and Enhanced Care Management). New York operations are branded Akido Medical. The Street Medicine program is the most prominent real-world deployment of Scope AI, using AI-guided intake and investigation on tablets to enable community health workers and field medical assistants to extend licensed-provider reach into street, field, and remote settings, including the Bay Area launch announced in January 2026. The Scope AI / Akido Care combination is additionally governed by the AI Collaborative, an AI ethics council Akido formed with Caltech's Merkin Institute and the Keck School of Medicine of USC Department of Surgery in August 2024.

Product and service1 record
1Scope AI
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Value-based primary care company focused on Medicaid and dual-eligible populations with a tech-enabled care model and street/community outreach. Directly comparable to Akido in target population, payer mix, and tech-augmented care delivery approach.

TypeDirect peer
Description

Risk-bearing, value-based primary care provider for complex Medicare and Medicaid populations; acquired by CVS Health for ~$10.6B. Comparable in risk-bearing model, complex-population focus, and tech-enabled workflow though primarily senior-focused.

TypeDirect peer
Description

Tech-enabled primary care platform combining owned clinics with a digital app for membership-based care; acquired by Amazon for ~$3.9B. Comparable in the AI/tech-augmented primary care thesis and clinic-plus-platform distribution, though originally commercial-insurance focused.

TypeDirect peer
Description

Family-owned, value-based primary care group serving low-income seniors with complex chronic conditions under full risk. Comparable in operating owned clinics, taking risk on outcomes, and serving high-acuity populations — though without Akido's AI platform layer.

TypeDirect peer
Description

Tech-enabled primary and urgent care provider operating multi-state clinics with proprietary EHR and AI-assisted documentation. Comparable in AI-augmented primary care delivery and clinic-plus-platform model, though more commercially focused.

TypeEmerging player
Description

AI-powered preventive primary care membership clinics with proprietary technology for diagnostics and care planning. Comparable in the AI-native care delivery thesis and emphasis on ScopeAI-like operating-system framing, though focused on preventive rather than safety-net care.

TypeEmerging player
Description

Value-based care enablement platform that partners with independent primary care practices to take risk in Medicare, Medicaid, and ACA. Comparable in risk-bearing care economics and focus on community-based providers, but does not own clinics or operate AI like ScopeAI.

TypeBroad incumbent
Description

Medicare Advantage insurer with proprietary Clover Assistant AI software deployed into primary care workflows to drive value-based outcomes. Comparable in combining an AI clinical assistant with risk-bearing payer/provider economics, though Clover is primarily a payer.

TypeBroad incumbent
Description

Integrated payer-provider system operating owned clinics, hospitals, and health plan across multiple states with deep value-based care infrastructure. Akido's Head of Healthcare Networks (Leslie Margolin) is a former National COO of Kaiser; comparable as the dominant incumbent in integrated, risk-bearing care Akido is attempting to disrupt.

10Babylon Health
TypeEmerging player
Description

Pioneer in AI-driven primary care triage, virtual care, and population health analytics with an AI clinical reasoning engine. Comparable in the AI-first operating system framing for primary care, though Babylon's business model centered on virtual-only care and it largely exited US markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors21 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Akido Labs

AI-Enabled Healthcare Deliveryakidolabs.com

Akido Labs is an AI-native care delivery company operating the Akido Care medical network across 96+ locations in California, Rhode Island, and New York, using its proprietary ScopeAI platform to deliver primary, specialty, and safety-net care to over 500,000 patients.

What Akido Labs does

Akido Labs is a Los Angeles-based, AI-native care delivery company founded in 2015 that operates an integrated medical network (the Akido Care network) spanning 96+ locations across California, Rhode Island, and New York, with 245 providers across 26 specialties serving more than 500,000 patients and 620,000 patient visits per year. Its foundational technology is ScopeAI, a proprietary clinical AI platform the company describes as 'the first AI operating system designed specifically for healthcare,' trained on what it calls the world's most powerful health data corpus and refined via reinforcement learning with human feedback (RLHF) from its in-network clinicians. ScopeAI is delivered to physicians through Akido Chart EMR, an in-house electronic medical record system that blends AI-generated diagnoses, treatment plans, and risk forecasts with clinician review, and is also deployed in field settings via tablets that enable community health workers to conduct AI-guided intakes for hard-to-reach populations.

Akido generates revenue primarily through fee-for-service and risk-bearing care contracts across commercial payers and government programs, including 100% Medi-Cal (California Medicaid) reimbursement for its street medicine and Enhanced Care Management (ECM) safety-net programs under CalAIM. The company's go-to-market combines direct care delivery (Akido Care clinics, mobile street-medicine units, Akido Medical in Brooklyn), channel partnerships (a JV with Rhode Island Primary Care Physicians Corporation, affiliation with Chaparral Medical Group), and targeted community programs (NYC ride-share driver mobile clinics, unhoused and substance-use-disorder populations in LA, Kern County, and the Bay Area). It has raised over $100M in cumulative venture funding, most recently a $60M Series B led by Oak HC/FT in May 2025, and reports 300% year-over-year run-rate growth into mid-nine figures as of January 2026. Strategic leadership additions in early 2026 (Matt Siegler as Chief Network Officer, Jack Greco on the board) and academic partnerships with Caltech's Merkin Institute and USC's Keck School of Medicine support a stated goal of national expansion in 2026.

Akido Labs firmographics

Firmographics
Name
Akido Labs
Legal name
Akido Labs, Inc.
Website
https://akidolabs.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
Akido Labs is an AI-native care delivery company operating the Akido Care medical network across 96+ locations in California, Rhode Island, and New York, using its proprietary ScopeAI platform to deliver primary, specialty, and safety-net care to over 500,000 patients.
Ownership category
akta.pro rank

Akido Labs industry classification

Industry
Product category
AI-Enabled Healthcare Delivery
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHLAFAFAN
Post-Acute Care Networks & Care Management Organizations
Healthcare & Life Sciences/Healthcare Providers & Systems/Post-Acute Care & Rehabilitation Facilities

Keywords

  • AI healthcare platform
  • Clinical intelligence software
  • Medical network services
  • Safety net healthcare
  • Street medicine programs

Where Akido Labs is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Akido Labs business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Patient Care Services (Akido Care): Direct healthcare delivery through the Akido Care medical network of 96+ locations across primary care and 26 specialties; 620,000 patient visits per year generating service revenue across commercial and government payers.
  2. Medi-Cal Reimbursements (Safety Net Programs): 100% of street medicine and Enhanced Care Management program costs are covered by Medi-Cal (California Medicaid) reimbursements, including services under the CalAIM Medicaid program.
  3. Risk-Bearing Care Models: Akido operates risk-bearing care models as an AI-native health system, taking financial accountability for patient outcomes; the company is seeing 300% growth into mid-nine figures run rate.

Pricing tiers

ModelBillingPrice
Other—Medi-Cal-covered safety net services (Street Medicine, Enhanced Care Management)

Go-to-market motion4 records

Distribution channels6 records

Marketing channels7 records

Akido Labs product offering

Product offering

Core offering

Akido Labs operates an AI-native health system that combines its proprietary ScopeAI clinical intelligence platform with a directly operated medical network (Akido Care) of 96+ locations and 245 providers across 26 specialties. ScopeAI delivers streamlined diagnosis, optimized diagnostics, personalized treatment planning, and forecasted health risk predictions, embedded within the Akido Chart EMR and refined via RLHF from Akido's clinicians. Patient-facing services include primary care, specialty care, and safety-net programs such as Street Medicine and Enhanced Care Management, serving 500,000+ patients across California, Rhode Island, and New York.

Product overview

Akido Labs operates a single integrated offering composed of a core AI platform delivered through a medical network, rather than a set of standalone products. The centerpiece is Scope AI — Akido's proprietary clinical AI operating system, which is delivered to clinicians through Akido Chart EMR. Scope AI powers all clinical workflows across the Akido Care medical network, which spans 96+ locations, 240+ providers across 26 specialties, and more than 500,000 patients across California, Rhode Island, and New York. Akido Care is organized into three service lines: Primary Care, Specialty Care, and Safety Net Services (which include the Street Medicine program launched in 2023 and Enhanced Care Management). New York operations are branded Akido Medical. The Street Medicine program is the most prominent real-world deployment of Scope AI, using AI-guided intake and investigation on tablets to enable community health workers and field medical assistants to extend licensed-provider reach into street, field, and remote settings, including the Bay Area launch announced in January 2026. The Scope AI / Akido Care combination is additionally governed by the AI Collaborative, an AI ethics council Akido formed with Caltech's Merkin Institute and the Keck School of Medicine of USC Department of Surgery in August 2024.

Differentiator

Problem solved

Functional benefit

Brands

  • Akido Care: Akido's primary care and specialty care medical network offering primary care, specialty care, and safety-net services (including street medicine and enhanced care management) across California, Rhode Island, and New York.
  • Scope AI
  • Akido Medical

Products and services

  • Scope AI

Quantifiable outcome

  • 53% of patients see a medical provider on their first day of engagement in street medicine programs
  • +12 more outcomes

Companies that use Akido Labs

Customer profile

Segments4 records

Ideal customer profiles4 records

Akido Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature6 records

Akido Labs partnerships and signals

Strategic signal

Scale indicators12 records

Recent moves8 records

Expansion highlights7 records

Akido Labs competitors and assessment

Company assessment

Direct peers

  • Cityblock Health: Value-based primary care company focused on Medicaid and dual-eligible populations with a tech-enabled care model and street/community outreach. Directly comparable to Akido in target population, payer mix, and tech-augmented care delivery approach.
  • Oak Street Health (CVS Health): Risk-bearing, value-based primary care provider for complex Medicare and Medicaid populations; acquired by CVS Health for ~$10.6B. Comparable in risk-bearing model, complex-population focus, and tech-enabled workflow though primarily senior-focused.
  • One Medical (Amazon): Tech-enabled primary care platform combining owned clinics with a digital app for membership-based care; acquired by Amazon for ~$3.9B. Comparable in the AI/tech-augmented primary care thesis and clinic-plus-platform distribution, though originally commercial-insurance focused.
  • ChenMed: Family-owned, value-based primary care group serving low-income seniors with complex chronic conditions under full risk. Comparable in operating owned clinics, taking risk on outcomes, and serving high-acuity populations — though without Akido's AI platform layer.
  • Carbon Health: Tech-enabled primary and urgent care provider operating multi-state clinics with proprietary EHR and AI-assisted documentation. Comparable in AI-augmented primary care delivery and clinic-plus-platform model, though more commercially focused.

Emerging players

  • Forward Health: AI-powered preventive primary care membership clinics with proprietary technology for diagnostics and care planning. Comparable in the AI-native care delivery thesis and emphasis on ScopeAI-like operating-system framing, though focused on preventive rather than safety-net care.
  • Aledade: Value-based care enablement platform that partners with independent primary care practices to take risk in Medicare, Medicaid, and ACA. Comparable in risk-bearing care economics and focus on community-based providers, but does not own clinics or operate AI like ScopeAI.
  • Babylon Health: Pioneer in AI-driven primary care triage, virtual care, and population health analytics with an AI clinical reasoning engine. Comparable in the AI-first operating system framing for primary care, though Babylon's business model centered on virtual-only care and it largely exited US markets.

Broad incumbents

  • Clover Health: Medicare Advantage insurer with proprietary Clover Assistant AI software deployed into primary care workflows to drive value-based outcomes. Comparable in combining an AI clinical assistant with risk-bearing payer/provider economics, though Clover is primarily a payer.
  • Kaiser Permanente: Integrated payer-provider system operating owned clinics, hospitals, and health plan across multiple states with deep value-based care infrastructure. Akido's Head of Healthcare Networks (Leslie Margolin) is a former National COO of Kaiser; comparable as the dominant incumbent in integrated, risk-bearing care Akido is attempting to disrupt.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Akido Labs social profiles

Digital presence

Akido Labs compliance and trust

Trust signal

Compliance3 records

Akido Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Akido Labs leadership team

Management profile

Number of profiles

Profiles12 records

Akido Labs subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Akido Labs funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors21 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Akido Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Akido Labs

What does Akido Labs do?

Akido Labs operates an AI-native health system that combines its proprietary ScopeAI clinical intelligence platform with a directly operated medical network (Akido Care) of 96+ locations and 245 providers across 26 specialties. ScopeAI delivers streamlined diagnosis, optimized diagnostics, personalized treatment planning, and forecasted health risk predictions, embedded within the Akido Chart EMR and refined via RLHF from Akido's clinicians. Patient-facing services include primary care, specialty care, and safety-net programs such as Street Medicine and Enhanced Care Management, serving 500,000+ patients across California, Rhode Island, and New York.

Is Akido Labs a public or private company?

Akido Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was Akido Labs founded?

Akido Labs was founded in 2015. It employs 101 to 250 people.

Where is Akido Labs based?

Akido Labs is headquartered in Los Angeles, United States, in the North America region.

How does Akido Labs make money?

Three revenue lines are on record. Patient Care Services (Akido Care) is the primary driver. The others are medi-Cal Reimbursements (Safety Net Programs) and risk-Bearing Care Models.

Who are Akido Labs's main competitors?

Direct peers on record are Cityblock Health, Oak Street Health (CVS Health), One Medical (Amazon), ChenMed and Carbon Health. Emerging players are Forward Health, Aledade and Babylon Health. Broad incumbents are Clover Health and Kaiser Permanente.

Does Akido Labs have an API?

No public API is recorded for Akido Labs.

What industry is Akido Labs in?

Akido Labs's product category is AI-Enabled Healthcare Delivery. Its primary akta.pro industry code is HLACAAAN, EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps, with a secondary code of HLAFAFAN, Post-Acute Care Networks & Care Management Organizations. Its NAICS code is 62151 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Endpoints NewsAkido is expanding AI for patient intake and diagnoses across 100 clinicsAkido is expanding its artificial intelligence technology for patient intake and diagnoses across 100 clinics, representing a significant scaling of AI deployment in healthcare settings.HIT ConsultantAkido Unveils First AI-Native Health System Powered by ScopeAIAkido announced the expansion of its ScopeAI ambient clinical intelligence technology across 100 clinics, virtual care operations, and field medicine services, serving 1 million patients across California, New York City, and Rhode Island. The company rebranded from Akido Labs to Akido and launched Akido Medical as the clinical brand for its facility network. The AI system demonstrated 5x more face-to-face patient engagement, a 96 Net Promoter Score, 55% reduction in Emergency Department utilization, and 53% same-day care access, and was evaluated against 203,000 real-world encounters using the TAMSS benchmark.PR NewswireAkido Announces the First AI-Native Health System in the USAkido announced it is building the first AI-native health system in the United States, deploying its ScopeAI technology across 100 clinics with access to 1 million patients in California, New York City, and Rhode Island. The company achieved 300% revenue growth from 2024 to 2025 and reported early outcomes including 53% same-day access, 83% three-month retention, and a 55% reduction in Emergency Department utilization versus national rates, alongside a 96 Net Promoter Score. The announcement comes amid a projected shortage of up to 86,000 U.S. physicians by 2036 according to the Association of American Medical Colleges, with Akido positioning its AI to reduce administrative burden on physicians.HcinnovationgroupA Growing Akido Calls Itself ‘First AI-Native Health System’ in U.S.Akido, a California-based healthcare company founded out of USC's Digital Health Lab in 2015, is positioning itself as the first "AI-native health system" in the United States and expanding its proprietary ScopeAI technology across its 100 clinics, virtual care, and field medicine services reaching 1 million patients in California, New York City, and Rhode Island. The company raised $60 million in Series B funding in 2025 led by Oak HC/FT with participation from Greco, SNR, and existing investors, and has hired new executives including a former Goldman Sachs engineer and the co-founder of Pearl who helped build the world's first FDA-cleared dental AI medical device. Akido has also launched an independent AI Clinical Advisory Council to provide external oversight of its AI systems and protocols.PR NewswireMission North Expands Health Practice Following 33% YoY Gains, Names Alex Hunter EVP of Health and Innovation as AI Redefines the Future of CareMission North expanded its Health practice after 33% year-over-year gains and named Alex Hunter as Executive Vice President of Health and Innovation. The practice now covers biopharma, medical technology, health systems, digital health, health IT, and AI-enabled care, with new client Heidi Health and AOR relationships with Sage and Virta Health.FierceHealthcareHow Akido Labs' new head of engineering brings consumer product thinking to healthcare deliveryMatt Rothstein, a technology executive who previously co-founded Final, Inc. (the product that became the Apple Card) and worked at Goldman Sachs and the National Library of Medicine, has joined Akido Labs as head of engineering at the AI-native healthcare company. Akido Labs, launched in 2015 and backed by Oak HC/FT and Y Combinator with over $100 million raised, operates Akido Care—a network of nearly 100 clinics with over 240 providers across 26 specialties serving more than 500,000 patients in three states. The company, named a Fierce 15 honoree of 2026, reports a 96 NPS, 100% year-over-year patient growth, and early results from its street medicine program showing 53% of patients see a provider on their first day of engagement.FierceHealthcareFierce Healthcare's Fierce 15 of 2026Fierce Healthcare announced its 2026 "Fierce 15" list, highlighting 15 healthcare innovation companies addressing systemic challenges including AI-powered insurance appeals, virtual care delivery, behavioral health integration, and early cancer detection. The honorees include firms like Akido Labs deploying AI across 100 clinics serving 500,000 patients, Artisight powering smart hospital platforms in nearly 500 hospitals, Claimable recovering over $30 million in denied claims, and SpotitEarly using canine biology combined with AI for cancer screening. The profiled companies collectively represent over $1.4 billion in disclosed funding and span diverse approaches to reducing clinician burnout, improving patient access, and driving value-based care outcomes.HcinnovationgroupAI-Based Platform Supports Community Health Workers in Street Medicine ProgramSeveral California-based organizations have partnered to deploy AI technology supporting street medicine programs, with the initiative expanding from Southern California to the Bay Area in March. Akido Labs is providing an AI platform that enables community health workers to conduct patient visits, document care, and streamline referrals under California's CalAIM Medicaid program. Early results show the model achieving 65% of patients seeing a provider on their first day of enrollment, 67% patient retention rates, and 24-hour prescription turnaround times for critical medications.KalwCan AI help treat Bay Area’s unhoused population?Akido Labs launched Scope AI in 2023 to assist street teams in treating unhoused patients in LA and Kern counties. The AI tool provides diagnoses and prescription recommendations, and case loads rose from 200 to 350 patients. Critics raise concerns about privacy, bias, and misdiagnosis.GlobeNewswireFuture Communities Institute, with Akido Labs, Five Keys, and ReImagine Freedom Launch the Bay Area’s First AI-Powered Safety Net ProgramFuture Communities Institute, with Five Keys, ReImagine Freedom, and Akido Labs, launched the Bay Area's first AI-powered safety net program. The program uses Akido's ScopeAI to guide community health workers in delivering care, including initiating substance use treatment within four hours. It aims to address the region's growing homelessness and lack of medical providers.